J. Ebben

468 total citations
12 papers, 339 citations indexed

About

J. Ebben is a scholar working on Nephrology, Hematology and Surgery. According to data from OpenAlex, J. Ebben has authored 12 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 3 papers in Hematology and 2 papers in Surgery. Recurrent topics in J. Ebben's work include Dialysis and Renal Disease Management (7 papers), Erythropoietin and Anemia Treatment (3 papers) and Central Venous Catheters and Hemodialysis (2 papers). J. Ebben is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Erythropoietin and Anemia Treatment (3 papers) and Central Venous Catheters and Hemodialysis (2 papers). J. Ebben collaborates with scholars based in United States, United Kingdom and France. J. Ebben's co-authors include A.J. Collins, Alan J. Collins, Kjellstrand Cm, Prakash Keshaviah, Allen R. Nissenson, Thomas A. Depner, Paul F. Emerson, Kailash Jindal, J. Michael Lazarus and Wendy L. St. Peter and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

J. Ebben

12 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Ebben United States	7	262	121	70	45	45	12	339
José Ignacio Merello Germany	12	247 0.9×	85 0.7×	107 1.5×	77 1.7×	22 0.5×	21	307
Joanna M Sturtevant Australia	6	211 0.8×	44 0.4×	48 0.7×	80 1.8×	10 0.2×	8	299
Eugene Schupak United States	9	197 0.8×	62 0.5×	139 2.0×	100 2.2×	33 0.7×	16	380
Ewa Wojtaszek Poland	9	114 0.4×	36 0.3×	27 0.4×	35 0.8×	17 0.4×	33	220
Sooraj Kuttykrishnan United States	7	223 0.9×	25 0.2×	42 0.6×	47 1.0×	9 0.2×	8	339
Man Nk France	10	211 0.8×	19 0.2×	44 0.6×	71 1.6×	11 0.2×	44	346
Inés Aragoncillo Spain	13	281 1.1×	70 0.6×	148 2.1×	115 2.6×	12 0.3×	29	391
Hans Furuland Sweden	11	201 0.8×	181 1.5×	32 0.5×	45 1.0×	56 1.2×	25	508
Kenneth Farrington United Kingdom	6	164 0.6×	304 2.5×	27 0.4×	14 0.3×	183 4.1×	10	424
Kiyoyuki Tokuyama Japan	8	263 1.0×	52 0.4×	23 0.3×	61 1.4×	6 0.1×	15	362

Countries citing papers authored by J. Ebben

Since Specialization

Citations

This map shows the geographic impact of J. Ebben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Ebben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Ebben more than expected).

Fields of papers citing papers by J. Ebben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Ebben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Ebben. The network helps show where J. Ebben may publish in the future.

Co-authorship network of co-authors of J. Ebben

This figure shows the co-authorship network connecting the top 25 collaborators of J. Ebben. A scholar is included among the top collaborators of J. Ebben based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Ebben. J. Ebben is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Ebben, J., Jens C. Eickhoff, Dustin A. Deming, et al.. (2024). QUIC: Phase 2 study of gemcitabine, cisplatin, quemliclustat (AB680), and zimberelimab (AB122) during first-line treatment of advanced biliary tract cancers (BTC)—Big Ten Cancer Research Consortium study BTCRC-GI22-564.. Journal of Clinical Oncology. 42(16_suppl). TPS4195–TPS4195. 1 indexed citations

2.

Collins, A.J., Jiannong Liu, & J. Ebben. (2004). Dialyser reuse-associated mortality and hospitalization risk in incident Medicare haemodialysis patients, 1998-1999. Nephrology Dialysis Transplantation. 19(5). 1245–1251. 14 indexed citations

3.

Collins, Alan J., et al.. (2000). Impact of hematocrit on morbidity and mortality.. PubMed. 20(4). 345–9. 74 indexed citations

4.

Collins, A.J., et al.. (2000). Hospitalization risks between Renagel phosphate binder treated and non-Renagel treated patients.. PubMed. 54(4). 334–41. 34 indexed citations

5.

Collins, A.J., et al.. (1998). Trends in anemia treatment with erythropoietin usage and patient outcomes. American Journal of Kidney Diseases. 32(6). S133–S141. 70 indexed citations

6.

Depner, Thomas A., Prakash Keshaviah, J. Ebben, et al.. (1996). Multicenter clinical validation of an on-line monitor of dialysis adequacy.. Journal of the American Society of Nephrology. 7(3). 464–471. 74 indexed citations

7.

Ebben, J., et al.. (1996). SODIUM (CONDUCTIVITY) DIALYSANCE IS MEMBRANE DEPENDENT. ASAIO Journal. 42(2). 81–81. 6 indexed citations

8.

Ebben, J., et al.. (1996). SODIUM (CONDUCTIVITY) DIALYSANCE IS MEMBRANE DEPENDENT. ASAIO Journal. 42(2). 81–81. 2 indexed citations

9.

Ebben, J., et al.. (1984). Central on-site preparation of substitution fluid for hemofiltration.. PubMed. 30. 195–8. 2 indexed citations

10.

Cm, Kjellstrand, et al.. (1981). Time of death, recovery of renal function, development of chronic renal failure and need for chronic hemodialysis in patients with acute tubular necrosis.. PubMed. 27. 45–50. 50 indexed citations

11.

Lynch, Robert E., et al.. (1978). Dialysis thrombocytopenia: parallel plate vs hollow fiber dialyzers.. PubMed. 24. 704–8. 11 indexed citations

12.

Streifel, Andrew J., et al.. (1978). Evaluation of Three Dry-Sterilized Hollow Fiber Artificial Kidneys. PubMed. 2(4). 347–359. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact